B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. - Wikidata - wikimedia - TriplyDB

B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening.

B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening.

http://www.wikidata.org/entity/Q44274431

about

Natriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass grafting Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent Effects of Low-Dose Recombinant Human Brain Natriuretic Peptide on Anterior Myocardial Infarction Complicated by Cardiogenic Shock.Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt.Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common beta-chain heteroreceptor.Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection.Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K(ATP) channels when administered at reperfusion following ischemia in rabbits Long-term effects of B-type natriuretic peptide infusion after acute myocardial infarction in a rat model Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans Lebetin 2, a Snake Venom-Derived Natriuretic Peptide, Attenuates Acute Myocardial Ischemic Injury through the Modulation of Mitochondrial Permeability Transition Pore at the Time of Reperfusion.Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia.KATP Channels in the Cardiovascular System.Infarct limitation by a protein kinase G activator at reperfusion in rabbit hearts is dependent on sensitizing the heart to A2b agonists by protein kinase C Exogenous Nitric Oxide Protects Human Embryonic Stem Cell-Derived Cardiomyocytes against Ischemia/Reperfusion Injury Role of B-type natriuretic peptide in epoxyeicosatrienoic acid-mediated improved post-ischaemic recovery of heart contractile function.Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury.Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study.Impact of nesiritide on renal function and mortality in patients suffering from heart failure.Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3',5'-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats Patents related to therapeutic activation of K(ATP) and K(2P) potassium channels for neuroprotection: ischemic/hypoxic/anoxic injury and general anesthetics.Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications.Natriuretic peptides modulate ATP-sensitive K(+) channels in rat ventricular cardiomyocytes.The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury.Contributions of cardiomyocyte-cardiac fibroblast-immune cell interactions in heart failure development.Novel approaches and opportunities for cardioprotective signaling through 3',5'-cyclic guanosine monophosphate manipulation.Natriuretic peptides in cardiometabolic regulation and disease.Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future.The cGMP/PKG pathway as a common mediator of cardioprotection: translatability and mechanism.Brain natriuretic peptide and right heart dysfunction after heart transplantation.Current and future uses of nesiritide.Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα.NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.B Type natriuretic peptide: a good omen in myocardial ischaemia?Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation.B-type natriuretic peptide and adiponectin releases in rat model of myocardial damage induced by isoproterenol administration.Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide.Predicting risk of coronary events and all-cause mortality: role of B-type natriuretic peptide above traditional risk factors and coronary artery calcium scoring in the general population: the Heinz Nixdorf Recall Study.

P2860

Q24644704-C8F2D49B-DBBB-4093-A0FC-3FAE4F0942A2 Q30234356-6E79487C-C300-49D2-8178-CC71623FC5FD Q33573360-1F6BCEE7-FDCA-40EF-A086-30D3A8860DF2 Q33615284-226E4EF8-19D2-4F82-8AB8-83EDD67DBB33 Q34048466-BD03D197-D90D-4565-8C6D-1E6A681F7CB6 Q34219629-2144E9C6-26C4-4526-9875-CEC01A2B3B8D Q34277031-C247509F-F223-402B-840C-01C8846659C6 Q34543457-ACB1F26A-60BA-4E92-B1B2-56A287F8C0B1 Q34891600-AC2E069B-7546-49C7-909A-452AB055693A Q35286339-C7026598-9107-4750-8896-AB3E9325ED81 Q35954229-97FD93AE-46FA-4A94-980E-D8E3331256D5 Q36129944-1F3C95DA-4142-4A87-80E5-35FFAC3E7414 Q36144664-2AD68107-2813-4DD3-BA9C-9EE8382CCE30 Q36236490-914FF3B0-7B47-41DD-BB9E-DA8D977F5845 Q36422478-69845CA4-9621-4010-B5C8-C12FC1B44FAF Q36893258-75B4227B-B7F7-4E82-8B50-4E9093745BD7 Q37049458-E7065455-4B81-4169-B181-73C3B080AB12 Q37240960-C413983A-A431-4318-AE6D-E293353C45C4 Q37298343-7BC640B3-83B0-47EA-B0E3-87128914C574 Q37329716-DB6E5907-E346-4772-AB17-EFE5B232E25A Q37404597-133063D5-CB8A-4056-A99E-5CF222DC0622 Q37481201-F79BC947-B24A-4E36-9984-DF25EF1CD563 Q37481320-72C204C1-5602-403B-83F7-FA6BC50D85E5 Q37626852-EEC360C3-CB80-4725-8BC8-3EC65256ABF5 Q37633999-340A41D0-9CD3-4049-A9AE-3B23B41AD3AF Q37926558-B9798F75-2045-47F0-AB78-B6C97D459498 Q38112347-7D700C98-8250-4DBD-A20F-2B7724A33DF7 Q38191314-EF66AE38-11FC-4822-9727-533C515435A7 Q38211333-FC76904E-9088-4A31-B137-2B84EB54180B Q38247701-AD5A44E2-46B7-4CF4-B042-23C92E75471A Q38258238-A6BFFF14-10F6-4385-813F-BCAFA5DB6BD9 Q38897414-3DBB9C56-C6DA-4ACC-85DE-EA1C5331A6E3 Q40442907-426AED1E-4957-4D9A-886F-9F9C4DAD1111 Q41189484-6812E222-FD41-4F3D-A94A-D675AF41E8CD Q41879996-7AC1575D-E25F-4D0A-B348-6E7D84589193 Q43014687-833ADF97-2239-4AD2-8E0E-BCE18B7EDEFF Q43116126-5BD25959-80CB-4BB3-8065-6266C43BD77F Q43154414-F02C9F1B-CF19-4D9F-8214-81956247CC88 Q44116990-A1D8016A-E10A-4A8F-A405-BE6F893AA13B Q44429060-D55192D8-3025-4583-9FA2-38158DC4888A

P2860

B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening.

http://www.wikidata.org/entity/Q44274431

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

B-type natriuretic peptide lim ...... arts via KATP channel opening.

@en

B-type natriuretic peptide lim ...... arts via KATP channel opening.

@nl

type

label

B-type natriuretic peptide lim ...... arts via KATP channel opening.

@en

B-type natriuretic peptide lim ...... arts via KATP channel opening.

@nl

prefLabel

B-type natriuretic peptide lim ...... arts via KATP channel opening.

@en

B-type natriuretic peptide lim ...... arts via KATP channel opening.

@nl

P1433

Q44274431-B825E7BC-73C3-44A9-BFB8-D97E9CD2DD12

P1476

Q44274431-2CBED9C7-A5E0-4489-AFAA-E998CAD91949

P2093

Q44274431-12216014-2808-4C1D-B2A5-075EFAB05D3F

Q44274431-1CCD33EE-D5ED-4ABD-A9FF-4375748449BB

Q44274431-285E4390-5D96-4E74-BC5F-28E146C24D59

Q44274431-65FEADF9-D498-4746-A11C-3A9F8E8C3C43

Q44274431-9CFCF208-D419-4F11-8426-3F8C3C266049

Q44274431-A5AB1C48-9546-484C-9498-AF45C86A994D

Q44274431-E3A305E3-D97A-4DAA-89FB-FF4709161D7A

Q44274431-F92E8126-9B36-49C9-A1D6-30C9A8B847F9

P2860

Q44274431-06117844-080C-4F8E-AB49-B538186F08A3

Q44274431-14B29FA8-BDE9-4167-8F10-ECE3D67F8640

Q44274431-28C35B18-1E39-491E-8097-C807F0393B7E

Q44274431-2A7D9981-ABB3-49A8-B92B-4E6166537D9C

Q44274431-314EDF47-6384-43D4-9AB9-5C4017E4DE00

Q44274431-3D3AB2C1-C430-410A-AD69-6BD26FE0D935

Q44274431-41A80545-62A6-4F9A-81E8-3881E62BE3C4

Q44274431-5966DE32-81A6-4D57-8FA9-CF7DECE88C2C

Q44274431-5C90D3E5-E738-4249-87AB-D857A9A5AFC3

Q44274431-5EA00D38-E560-41E0-9C87-84264C1B4BE6

P304

Q44274431-85B3081C-017C-450C-AEF4-4274C89A895B

P31

Q44274431-26214B30-A6FE-446F-B2DF-80D076B44064

P356

Q44274431-071BF7CC-65A5-4F16-BB38-01BA5E85A683

P433

Q44274431-9277EF8F-6B52-491D-BEF9-101D6C357926

P478

Q44274431-469D63C0-C36C-4BE8-A5A5-7482AD35F967

P577

Q44274431-C9D04FAF-0653-4D59-94C9-D9E7C7D2C105

P5875

Q44274431-20FC433A-B9AC-447A-9095-23F75544B8A2

P698

Q44274431-BB9B223D-E46C-4A3C-9DA2-75F6F7ED319A

P356

AJPHEART.00902.2002

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

B-type natriuretic peptide lim ...... arts via KATP channel opening.

@en

P2093

Annamaria Onody

http://www.w3.org/2001/XMLSchema#string

Claus Martin

http://www.w3.org/2001/XMLSchema#string

Derek M Yellon

http://www.w3.org/2001/XMLSchema#string

Gary F Baxter

http://www.w3.org/2001/XMLSchema#string

Gerd Heusch

http://www.w3.org/2001/XMLSchema#string

Peter Ferdinandy

http://www.w3.org/2001/XMLSchema#string

Rainer Schulz

http://www.w3.org/2001/XMLSchema#string

Savio P D'Souza

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular biology of the natriuretic peptides and their receptors

Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina

Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury

Natriuretic peptide signalling: molecular and cellular pathways to growth regulation.

Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use.

Signal transduction of ischemic preconditioning.

Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Signal transduction by guanylyl cyclases.

Role of cyclic nucleotides in heart metabolism.

ATP-sensitive potassium channels and myocardial preconditioning.

P304

H1592-600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00902.2002

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10955985

http://www.w3.org/2001/XMLSchema#string

P698

12521930

http://www.w3.org/2001/XMLSchema#string